Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Johnson and Johnson
Colorcon
Express Scripts
Mallinckrodt

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FINASTERIDE

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

All Clinical Trials for Finasteride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status Cancer and Leukemia Group B Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status Eastern Cooperative Oncology Group Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status European Organisation for Research and Treatment of Cancer - EORTC Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status National Cancer Institute (NCI) Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
NCT00002651 Hormone Therapy in Treating Men With Stage IV Prostate Cancer Unknown status NCIC Clinical Trials Group Phase 3 1995-05-01 RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Finasteride

Condition Name

Condition Name for Finasteride
Intervention Trials
Healthy 10
Benign Prostatic Hyperplasia 10
Androgenetic Alopecia 7
Prostatic Hyperplasia 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Finasteride
Intervention Trials
Prostatic Hyperplasia 21
Hyperplasia 19
Alopecia 11
Alopecia Areata 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Finasteride

Trials by Country

Trials by Country for Finasteride
Location Trials
United States 116
Canada 19
Korea, Republic of 8
Mexico 6
Argentina 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Finasteride
Location Trials
Texas 10
Florida 8
California 7
Maryland 6
Illinois 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Finasteride

Clinical Trial Phase

Clinical Trial Phase for Finasteride
Clinical Trial Phase Trials
Phase 4 8
Phase 3 16
Phase 2 15
[disabled in preview] 20
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Finasteride
Clinical Trial Phase Trials
Completed 39
Recruiting 7
Terminated 5
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Finasteride

Sponsor Name

Sponsor Name for Finasteride
Sponsor Trials
GlaxoSmithKline 5
Merck Sharp & Dohme Corp. 4
National Cancer Institute (NCI) 4
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Finasteride
Sponsor Trials
Industry 42
Other 41
NIH 16
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Johnson and Johnson
Colorcon
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.